MPS-II PDF Print E-mail
Written by cdutcher   
Thursday, 03 May 2012 19:24

 

MPS II (Hunter syndrome)

 

 

MPS II is one of the mucopolysaccharide diseases and is also known as Hunter syndrome. It takes its name from Charles Hunter, the professor of medicine in Manitoba, Canada, who first described two brothers with the disease in 1917. MPS II has a wide range of symptoms that vary in severity.

There is no cure for MPS diseases, but there are ways of managing and treating the problems they cause, including enzyme replacement therapies.

What causes the disease?

Children with MPS II are missing an enzyme called iduronate sulfatase, which is essential in cutting up the mucopolysaccharides called dermatan and heparan sulphate. The incomplete broken down mucopolysaccharides remain stored in cells in the body causing progressive damage. Babies may show little sign of the disease, but as more and more cells become damaged, symptoms start to appear.

How common is Hunter Syndrome?

This is a rare condition affecting 1 in 100,000 to 1 in 150,000 males. There is an estimate in the United States that 1 in 25,000 births will result in some form of MPS.

How is the disease inherited?

MPS II occurs in boys, and girls may be carriers of the gene for MPS II. Although rare, MPS II has been diagnosed in girls.

Is there a Cure for MPS II?

There is no cure but treatments such as enzyme replacement therapies can help make the disease more manageable. Enzyme replacement therapy . http://www.elaprase.com/

 

 

Last Updated on Thursday, 17 May 2012 18:34
 
Would you have a child if there was a 50% chance they would have a severe medical disorder?
 
остекление балконов и лоджий остекление лоджий цены на остекление балконов
Christopher Dutcher
CTMAD
CTMAD
Courage2Make
Blog
Photobucket